BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yan L, Luo Y, Xiao J, Lin L. Non-enhanced ultrasound is not a satisfactory modality for measuring necrotic ablated volume after radiofrequency ablation of benign thyroid nodules: a comparison with contrast-enhanced ultrasound. Eur Radiol 2021;31:3226-36. [PMID: 33128600 DOI: 10.1007/s00330-020-07398-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Ren L, Yan L, Fei X, Luo Y. Intraobserver and Interobserver Consistency Evaluation of Carotid Plaque Volume Measured by Different 3-Dimensional Ultrasound Methods. Ultrasound Q 2023. [PMID: 36716417 DOI: 10.1097/RUQ.0000000000000635] [Reference Citation Analysis]
2 Boers T, Braak SJ, Rikken NET, Versluis M, Manohar S. Ultrasound imaging in thyroid nodule diagnosis, therapy, and follow-up: Current status and future trends. J Clin Ultrasound 2023. [PMID: 36655705 DOI: 10.1002/jcu.23430] [Reference Citation Analysis]
3 Li H, Wang Q, Sui G, Lin Y, Luo Q, Dong P, Zhu L, Wang H, Teng D. Value of CEUS combined with feeding artery ablation in the microwave ablation of large solid benign thyroid nodules. Eur Radiol 2022. [DOI: 10.1007/s00330-022-09313-1] [Reference Citation Analysis]
4 Zhu Y, Jiao Z, Zhu L, Xie F, Song Q, Yan L, Luo Y, Zhang M. A New Perspective for Predicting the Therapeutic Success of RFA in Solid BTNs: Quantitative Initial RFA Ratio by Contrast-Enhanced Ultrasound. Front Endocrinol 2022;13:904459. [DOI: 10.3389/fendo.2022.904459] [Reference Citation Analysis]
5 Yin T, Zheng B, Lian Y, Li H, Tan L, Xu S, Liu Y, Wu T, Ren J. Contrast-enhanced ultrasound improves the potency of fine-needle aspiration in thyroid nodules with high inadequate risk. BMC Med Imaging 2022;22:83. [PMID: 35501723 DOI: 10.1186/s12880-022-00805-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Fite BZ, Wang J, Ghanouni P, Ferrara KW. A Review of Imaging Methods to Assess Ultrasound-Mediated Ablation. BME Frontiers 2022;2022:1-17. [DOI: 10.34133/2022/9758652] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Lai L, Liu Z, Zhang J, Ni X, Liu J, Luo T, Dong Y, Zhou J. Effect of Hashimoto's thyroiditis on the extent of the ablation zone in early stages of ultrasound-guided radiofrequency ablation for papillary thyroid microcarcinoma: a large cohort study of 772 patients. Int J Hyperthermia 2022;39:397-404. [PMID: 35209788 DOI: 10.1080/02656736.2022.2041736] [Reference Citation Analysis]
8 Yan L, Li X, Xiao J, Li Y, Zhu Y, He H, Luo Y. Contrast-enhanced ultrasound is a reliable and reproducible assessment of necrotic ablated volume after radiofrequency ablation for benign thyroid nodules: a retrospective study. Int J Hyperthermia 2022;39:40-7. [PMID: 34936850 DOI: 10.1080/02656736.2021.1991009] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Lan Y, Li N, Song Q, Zhang MB, Luo YK, Zhang Y. Correlation and agreement between superb micro-vascular imaging and contrast-enhanced ultrasound for assessing radiofrequency ablation treatment of thyroid nodules: a preliminary study. BMC Med Imaging 2021;21:175. [PMID: 34809604 DOI: 10.1186/s12880-021-00697-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Radzina M, Ratniece M, Putrins DS, Saule L, Cantisani V. Performance of Contrast-Enhanced Ultrasound in Thyroid Nodules: Review of Current State and Future Perspectives. Cancers (Basel) 2021;13:5469. [PMID: 34771632 DOI: 10.3390/cancers13215469] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
11 Yan L, Luo Y. Prediction of nodule regrowth after radiofrequency ablation of benign thyroid nodules. Int J Hyperthermia 2021;38:11-2. [PMID: 33400887 DOI: 10.1080/02656736.2020.1867243] [Reference Citation Analysis]
12 He H, Song Q, Lan Y, Yan L, Xiao J, Zhang Y, Luo Y. Efficacy and safety of ultrasound-guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma in patients aged 55 years or older: a retrospective study. Int J Hyperthermia 2021;38:604-10. [PMID: 33853489 DOI: 10.1080/02656736.2021.1912416] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
13 Yan L, Luo Y. Response to letter to the editor from Dr. Bernardi regarding suitability of residual vital ratio for prediction of local regrowth following radiofrequency ablation for benign thyroid nodules. Int J Hyperthermia 2021;38:189-90. [PMID: 33576298 DOI: 10.1080/02656736.2021.1883128] [Reference Citation Analysis]
14 Bernardi S, Palermo A, Grasso RF, Fabris B, Stacul F, Cesareo R. Current Status and Challenges of US-Guided Radiofrequency Ablation of Thyroid Nodules in the Long Term: A Systematic Review. Cancers (Basel) 2021;13:2746. [PMID: 34205994 DOI: 10.3390/cancers13112746] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]